Skip to content

the Impact of EECP on Intraocular Pressure

Study of the Impact of Enhanced Extracorporeal Counterpulsation Treatment on Intraocular Pressure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01774188
Enrollment
40
Registered
2013-01-23
Start date
2012-07-31
Completion date
2013-03-31
Last updated
2013-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular Pressure

Keywords

Enhanced Extracorporeal Counterpulsation, intraocular pressure, Pen type tonometer

Brief summary

EECP therapy may affect the intraocular pressure while improving the ischemia systemic organ blood perfusion the same time. The present study investigated the impact of Enhanced Extracorporeal Counterpulsation treatment on the intraocular pressure.

Detailed description

Select 40 cases of patients (80eyes) who had counter pulsation treatment at Enhanced External Counter Pulsation (EECP) Specialist in First Affiliated Hospital of Sun Yat-sen University during Apr 2012 - Mar 2013. Separated the patients into 2 groups according to having glaucoma history or not.The cases whose eyes have erythralgia and who have received corneal surgery or intraocular surgery in recent one month are excluded.

Interventions

None listed

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* counter Enhanced External Counter Pulsation treatment

Exclusion criteria

* whose eyes have erythralgia * who have received corneal surgery or intraocular surgery in recent one month * Hemorrhagic disease * Atrial fibrillation * Aortic regurgitation * thrombophlebitis or infection lesions * severe hypertensive

Design outcomes

Primary

MeasureTime frame
intraocular pressure7 weeks

Secondary

MeasureTime frame
ophthalmic and retina artery blood flow rate7 weeks

Other

MeasureTime frame
Blood Pressure7 weeks

Countries

China

Contacts

Primary ContactWen-hui zhu, MD
dctzwh@139.com862087755766

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026